fda import alert semaglutide tirzepatide green list introduces "Green List" for GLP-1 drug ingredients | Bob Durkin posted on the topic Food and Drug Administration Launches

eligibility is determined by a licensed clinician

Rhabdomyolysis associated with concurrent use of sitagliptin and simvastatin

Monitoring focuses on glucose control, kidney context, lipids, GI symptoms, gallbladder/pancreas symptoms, and thyroid-history cautions

As with Metformin, Acarbose is FDA approved for the treatment of diabetes mellitus, type 2

"For example, you may be doing well at 5 mg, so that could be your long-term dose rather than continuing to increase the dosage." Zepbound dosing Zepbound, the version approved for weight loss, comes in the same six dosages as Mounjaro: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg and is usually increased at a similar pace: Week 1-4: 2.5 mg Week 5-8: 5 mg Week 9-12: 7.5 mg Week 13-16: 10 mg Week 17-20: 12.5 mg Week 21-onward: 15 mg "Similar to Mounjaro or other GLP-1 medications, you'll be closely monitored to see how well you do on a specific dosage, and that will tend to determine if you increase," says Sowa

Because of this, people can see more weight reduction and better glycemic control